ATE381328T1 - Heterosubstituierte taxan-c10-acetate als antitumormittel - Google Patents

Heterosubstituierte taxan-c10-acetate als antitumormittel

Info

Publication number
ATE381328T1
ATE381328T1 AT01906951T AT01906951T ATE381328T1 AT E381328 T1 ATE381328 T1 AT E381328T1 AT 01906951 T AT01906951 T AT 01906951T AT 01906951 T AT01906951 T AT 01906951T AT E381328 T1 ATE381328 T1 AT E381328T1
Authority
AT
Austria
Prior art keywords
heterosubstituted
acetate
taxan
tumor agent
substituent
Prior art date
Application number
AT01906951T
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Application granted granted Critical
Publication of ATE381328T1 publication Critical patent/ATE381328T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT01906951T 2000-02-02 2001-02-02 Heterosubstituierte taxan-c10-acetate als antitumormittel ATE381328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17966900P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
ATE381328T1 true ATE381328T1 (de) 2008-01-15

Family

ID=22657495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01906951T ATE381328T1 (de) 2000-02-02 2001-02-02 Heterosubstituierte taxan-c10-acetate als antitumormittel

Country Status (21)

Country Link
US (4) US6664275B2 (de)
EP (1) EP1165068B1 (de)
JP (1) JP2003521514A (de)
KR (1) KR20020002488A (de)
CN (1) CN1362876A (de)
AT (1) ATE381328T1 (de)
AU (1) AU776767B2 (de)
BR (1) BR0104350A (de)
CA (1) CA2368502A1 (de)
CZ (1) CZ20013523A3 (de)
DE (1) DE60131927D1 (de)
HK (1) HK1047896A1 (de)
HU (1) HUP0200750A3 (de)
IL (1) IL145639A (de)
MX (1) MXPA01009924A (de)
NO (1) NO20014756L (de)
NZ (1) NZ514406A (de)
PL (1) PL350027A1 (de)
TW (1) TWI257390B (de)
WO (1) WO2001056564A1 (de)
ZA (1) ZA200108052B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2367661A1 (en) * 2000-02-02 2001-08-09 Robert A. Holton Taxane formulations having improved solubility
NZ514406A (en) * 2000-02-02 2005-01-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents
BR0313197A (pt) 2002-08-02 2005-08-09 Immunogen Inc Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
US7390898B2 (en) * 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
EP1810968A3 (de) * 2003-09-25 2007-08-08 Tapestry Pharmaceuticals, Inc. 9, 10-a, a-OH-Taxan-Analoge und Herstellungsverfahren dafür
EP1785416A3 (de) 2003-09-25 2007-05-30 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-OH-Taxan-Analogen und Herstellungsverfahren dafür
CN1712399B (zh) * 2004-06-24 2010-08-11 中国医学科学院药物研究所 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途
KR100627436B1 (ko) * 2005-10-18 2006-09-22 주식회사 시드컴 차량용 요일체킹장치
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
AU2008229041A1 (en) * 2007-03-19 2008-09-25 Inflabloc Pharmaceuticals, Inc. Cobalamin taxane bioconjugates
MX2010011165A (es) * 2008-04-10 2011-02-22 Abraxis Bioscience Llc Composiciones de derivados de taxano hidrofobos y sus usos.
TW200942233A (en) * 2008-04-10 2009-10-16 Abraxis Bioscience Llc Compositions of hydrophobic taxane derivatives and uses thereof
CA2786569C (en) 2010-01-29 2019-04-09 Perkinelmer Health Sciences, Inc. Sample-to-answer microfluidic cartridge
EP3239139B1 (de) 2010-05-27 2020-10-28 Ningbo Combireg Pharmaceutical Technology Co. Ltd Chemische synthese sowie antitumor- und antimetastasewirkung eines konjugats mit doppelfunktion
JP6498125B2 (ja) 2012-12-21 2019-04-10 マイクロニクス, インコーポレイテッド 流体回路および関連する製造方法
KR20150096788A (ko) 2012-12-21 2015-08-25 마이크로닉스 인코포레이티드. 마이크로 유체공학 용도를 위한 저탄성 막
CN104919035B (zh) 2012-12-21 2017-08-11 精密公司 便携式荧光检测系统和微测定盒
WO2014182844A1 (en) 2013-05-07 2014-11-13 Micronics, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
EP2994543B1 (de) 2013-05-07 2018-08-15 Micronics, Inc. Vorrichtung zur herstellung und analyse von nukleinsäuren
CA2911303C (en) 2013-05-07 2021-02-16 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
US11300578B2 (en) 2016-09-19 2022-04-12 Roche Molecular Systems, Inc. Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system
WO2021252923A1 (en) 2020-06-12 2021-12-16 Genmark Diagnostics, Inc. Systems and methods for assessing bays on diagnostic devices

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
DK0552041T3 (da) 1992-01-15 2000-10-09 Squibb & Sons Inc Enzymatiske fremgangsmåder til spaltning af enantiomerblandinger af forbindelser, der er nyttige som mellemprodukter ved fr
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
FR2702212B1 (fr) 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
ES2205663T3 (es) 1993-06-11 2004-05-01 PHARMACIA & UPJOHN COMPANY Uso antineoplasico de delta 6,7-taxoles y composiciones farmaceuticas que los contienen.
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
EP0788493A1 (de) 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid-derivate, deren herstellung und deren verwendung als anti-tumor-mittel
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
WO1997009979A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
TW338042B (en) * 1995-10-31 1998-08-11 Clary Kk Process for producing all trans-form polyprenols
US5756536A (en) * 1995-11-03 1998-05-26 Purdue Research Foundation Microbial transformation of taxol and cephalomannine
US5899043A (en) * 1995-12-18 1999-05-04 Engineering Certifiers Ltd. Ductile-failure anchors for concrete elements
US5767297A (en) 1997-02-05 1998-06-16 Ensuiko Sugar Refining Co., Ltd. Taxoid derivative and method of producing thereof
AU724499B2 (en) 1996-05-06 2000-09-21 Florida State University 1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
AU710156B2 (en) 1996-07-15 1999-09-16 Kabushiki Kaisha Yakult Honsha Taxane derivatives and drugs containing the same
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
CA2206739C (en) 1997-06-03 2006-10-10 Ensuiko Sugar Refining Co., Ltd. Taxoid derivative and method of producing thereof
SE9702776D0 (sv) * 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
NZ514406A (en) * 2000-02-02 2005-01-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents
KR20010111580A (ko) 2000-02-02 2001-12-19 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 개선된 용해도를 갖는 탁산 제형물

Also Published As

Publication number Publication date
HK1047896A1 (zh) 2003-03-14
IL145639A (en) 2007-02-11
US6872837B2 (en) 2005-03-29
US20020068755A1 (en) 2002-06-06
ZA200108052B (en) 2003-12-01
AU3479201A (en) 2001-08-14
US20050143447A1 (en) 2005-06-30
TWI257390B (en) 2006-07-01
HUP0200750A2 (hu) 2002-07-29
WO2001056564A1 (en) 2001-08-09
IL145639A0 (en) 2002-06-30
NO20014756L (no) 2001-11-29
EP1165068A1 (de) 2002-01-02
JP2003521514A (ja) 2003-07-15
HUP0200750A3 (en) 2005-02-28
CN1362876A (zh) 2002-08-07
BR0104350A (pt) 2002-01-02
US7157474B2 (en) 2007-01-02
CZ20013523A3 (cs) 2002-03-13
EP1165068B1 (de) 2007-12-19
CA2368502A1 (en) 2001-08-09
AU776767B2 (en) 2004-09-23
MXPA01009924A (es) 2003-08-01
NO20014756D0 (no) 2001-10-01
NZ514406A (en) 2005-01-28
PL350027A1 (en) 2002-10-21
US20070249707A1 (en) 2007-10-25
KR20020002488A (ko) 2002-01-09
US6664275B2 (en) 2003-12-16
US20040024051A1 (en) 2004-02-05
DE60131927D1 (de) 2008-01-31

Similar Documents

Publication Publication Date Title
ATE381328T1 (de) Heterosubstituierte taxan-c10-acetate als antitumormittel
MY137637A (en) C7 ester substituted taxanes
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
NO20014758L (no) C(7)-heterosubstituerte acetattaxaner som antitumormidler
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
DE60134814D1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
DE60138853D1 (de) C10-taxanester als antitumormittel
DE60133600D1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
BG105966A (en) C7 carbonate substituted taxanes and their application as antitumor agents
ATE282611T1 (de) Stolonoxide
MXPA01007972A (es) Esteres de taxanos c10 sustituidos.
SG125888A1 (en) C10 carbonate substituted taxanes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties